| A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome. | |
| | |
MedLine Citation:
|
PMID: 20562673 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
OBJECTIVES: The G-protein Gq, encoded by GNAQ, is involved in glucose metabolism. The GNAQ promoter harbours three polymorphisms. The TT(-695/-694)GC polymorphism was already shown to affect Gq transcription. Accordingly, we (i) characterized the GNAQ promoter polymorphisms G(-173)A and G(-168)A, (ii) investigated potential influences upon the TT(-695/-694)GC polymorphism and (iii) studied the associations with metabolic abnormalities in polycystic ovary syndrome (PCOS). METHODS: Characterization of the polymorphisms was performed with electrophoretic mobility shift assays and reporter assays. Inhibition of lipolysis and Gq expression were measured in adipocytes isolated from female mammary tissue. We genotyped 266 healthy Caucasians, 265 women with PCOS, and 293 healthy, age-matched female controls to associate GNAQ promoter polymorphisms and haplotypes with anthropometric and metabolic variables. RESULTS: The A(-168) allele was associated with significantly decreased transcriptional activity and altered transcription factor binding, whereas the G(-173)A polymorphism appeared functionally silent. Linkage and haplotype frequencies analysis resulted in four common haplotypes. In adipose tissue, a 44% higher Gq mRNA concentration was observed in homozygous GC(-695/-694)-G(-168) haplotypes compared with homozygous TT(-695/-694)-G(-168) haplotypes (P=0.046). This was associated with increased insulin inhibition of lipolysis in isolated adipocytes. In PCOS patients, the homozygous GC-G haplotype was associated with decreased insulin resistance and body mass index (BMI) compared with the homozygous TT-G haplotype (homeostatic model assessment of insulin resistance: 3.4+/-0.4 vs. 5.6+/-0.7 mmol/l x mmol/l2, P=0.001; fasting insulin: 86.6+/-11.9 vs. 128.8+/-16.5 pmol/l, P=0.003; BMI: 29.3+/-1.2 vs. 33.9+/-1.3 kg/m2, P=0.002). No association with BMI was found in healthy women. CONCLUSION: G(-168)A is functionally relevant and in linkage with TT(-695/-694)GC. GNAQ promoter diplotypes are associated with insulin resistance and obesity in PCOS. |
| | |
Authors:
|
Stefanie Klenke; Susanne Tan; Susanne Hahn; Klaus Mann; Hans Hauner; Iris Manthey; Jürgen Peters; Winfried Siffert; Ulrich H Frey |
Related Documents
:
|
10775173 - Regulation of pulsatile luteinizing hormone secretion by insulin in the diabetic male l... 17347533 - Thiazolidinediones and fertility in polycystic ovary syndrome (pcos). 17375403 - How should postprandial glycemia be treated? |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Pharmacogenetics and genomics Volume: 20 ISSN: 1744-6880 ISO Abbreviation: Pharmacogenet. Genomics Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101231005 Medline TA: Pharmacogenet Genomics Country: United States |
Other Details:
|
Languages: eng Pagination: 476-84 Citation Subset: IM |
Affiliation:
|
Institut für Pharmakogenetik, Universität Duisburg-Essen and Universitätsklinikum Essen, Essen, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Autophagy during common bacterial and viral infections of children.
Next Document: Association between LEP and LEPR gene polymorphisms and dyslipidemia in patients using atypical anti...